Loading...
Please wait, while we are loading the content...
Similar Documents
Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms
| Content Provider | MDPI |
|---|---|
| Author | Alarcon, Neftali Ortega Jaramillo, Maddy Mansour, Heidi M. Sun, Bo |
| Copyright Year | 2022 |
| Description | For decades, vaccines have played a significant role in protecting public and personal health against infectious diseases and proved their great potential in battling cancers as well. This review focused on the current progress of therapeutic subunit vaccines for cancer immunotherapy. Antigens and adjuvants are key components of vaccine formulations. We summarized several classes of tumor antigens and bioinformatic approaches of identification of tumor neoantigens. Pattern recognition receptor (PRR)-targeting adjuvants and their targeted delivery platforms have been extensively discussed. In addition, we emphasized the interplay between multiple adjuvants and their combined delivery for cancer immunotherapy. |
| Starting Page | 1448 |
| e-ISSN | 19994923 |
| DOI | 10.3390/pharmaceutics14071448 |
| Journal | Pharmaceutics |
| Issue Number | 7 |
| Volume Number | 14 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2022-07-11 |
| Access Restriction | Open |
| Subject Keyword | Pharmaceutics Therapeutic Vaccine Tumor Antigens Adjuvants Delivery Systems Combination Therapies |
| Content Type | Text |
| Resource Type | Article |